Physician profile
Eugene E Benfield
NPI 1851381289
$2,259.31
in general payments reported to CMS, 2019-2025
13 companies · $731 in 2025
The $731 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $409 · 2021: $268 · 2022: $248 · 2023: $147 · 2024: $113 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Food and Beverage | $490.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $882.33 | 2019-2025 | Precision7, Total30, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $296.35 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $223.52 | 2019-2024 | Acuvue |
| Sun Pharmaceutical Industries INC. | $196.22 | 2023-2025 | Cequa |
| Coopervision INC. | $165.15 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $139.86 | 2022 | |
| Shire North American Group INC | $133.01 | 2019 | |
| Aerie Pharmaceuticals, INC. | $100.00 | 2019 | |
| Dompe US, INC. | $41.33 | 2024 | Oxervate |
| Optos, INC. | $35.05 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $15.30 | 2022 | |
| Allergan, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Benfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.